Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203

Increased expression of eicosanoids in cancer has been associated with adverse prognosis. We performed a randomized phase II trial to test the hypothesis that inhibitors of two eicosanoid pathways (cyclooxygenase-2 [COX-2], celecoxib and 5-lipoxygenase [5-LOX], zileuton) added to chemotherapy would...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2008-02, Vol.26 (6), p.848-855
Hauptverfasser: EDELMAN, Martin J, WATSON, Dee, BEDOR, Michelle, VOKES, Everett E, GREEN, Mark J, XIAOFEI WANG, MORRISON, Carl, KRATZKE, Robert A, JEWELL, Scott, HODGSON, Lydia, MAUER, Ann M, GAJRA, Ajeet, MASTERS, Gregory A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!